Package tests

Important for: Anemia, pregnancy, nutritional deficiencies

Express diagnosis of STDs using PCR

A COMPLETE SET OF TESTS THAT CHECK: • Standard lipid levels (cholesterol, triglycerides, HDL, LDL, non-HDL) • Apolipoprotein A1 and B (proteins in lipoprotein particles) • Lipoprotein (a) – a genetic variant of LDL • High sensitivity C-reactive protein (hs-CRP) – marker of inflammation • Lp-PLA2 (PLAC) enzyme activity – linked to vascular inflammation WHAT THIS TEST SUITE REVEALS: • Whether “bad” fats (LDL, non-HDL) are elevated and “good” (HDL) are sufficient • The balance between protective and atherogenic particles via Apo A1 / Apo B • Possible inherited risk through elevated Lp(a) • Systemic low-grade inflammation status via hs-CRP • Activity or potential instability of atherosclerotic plaques via Lp-PLA2

A COMPLETE SET OF TESTS THAT CHECK: • Total cholesterol, HDL (“good”) cholesterol, LDL (“bad”) cholesterol, triglycerides, and non-HDL cholesterol • Apolipoprotein A1 and Apolipoprotein B — protein markers of protective vs atherogenic lipoproteins • Lipoprotein(a) — variant LDL with additional risk from genetic predisposition • High sensitivity C-reactive protein (hs-CRP) — systemic low-grade inflammation marker • Lp-PLA₂ (PLAC) enzyme activity — linked to vascular inflammation and plaque stability • Homocysteine — amino acid associated with endothelial damage and vascular risk • Fibrinogen — coagulation factor and marker of clotting tendency WHAT THIS TEST SUITE REVEALS: • The profile of blood lipids and how balanced they are (good vs bad cholesterol) • The number and potential atherogenic strength of lipoprotein particles via apoA1 / apoB • Genetic risk from elevated Lp(a) that may not be seen in usual lipid tests • Whether inflammation is contributing to vascular injury (hs-CRP, Lp-PLA₂) • Elevated homocysteine suggests endothelial dysfunction, elevated risk for atherosclerosis • High fibrinogen indicates increased clotting potential and vascular stress • A more comprehensive cardiovascular risk categorization than classic lipid panels alone • Helps clinicians decide on more aggressive prevention, monitoring, or therapeutic strategies beyond cholesterol-lowering agents

A COMPLETE SET OF TESTS THAT CHECK: • Presence of Chlamydia trachomatis by PCR • Presence of Neisseria gonorrhoea by PCR • Presence of Mycoplasma genitalium by PCR • Presence of Ureaplasma species (e.g. U. urealyticum, U. parvum) by PCR • Presence of Trichomonas vaginalis by PCR • Presence of Gardnerella vaginalis by PCR • Presence of Herpes Simplex Virus types I and II by PCR WHAT THIS TEST SUITE REVEALS: • Which of these common sexually transmitted pathogens (if any) are present in the sample (positive/negative) • Possibility of co-infections — detection of multiple pathogens in the same specimen • Specific pathogen(s) responsible for symptoms or infection, enabling targeted therapy • Detection of asymptomatic infections, important for prevention and early intervention • Guidance for clinicians on appropriate antimicrobial or antiviral treatment based on identified organism(s) • Helps in monitoring response to treatment and preventing complications associated with untreated STIs (e.g. pelvic inflammatory disease, transmission to partner)

A COMPLETE SET OF TESTS THAT CHECK: • Electrolyte balance and kidney filtration (sodium, potassium, chloride, bicarbonate, urea, creatinine, eGFR) • Liver health and protein synthesis (bilirubin, AST, ALT, GGT, alkaline phosphatase, total protein, albumin, globulin) • Mineral balance in body (calcium, phosphate, magnesium, uric acid) • Blood sugar regulation (glucose) • Lipid levels (triglycerides, total cholesterol, HDL, LDL (calculated), non-HDL) WHAT THIS TEST SUITE REVEALS: • Whether there are abnormalities in blood — e.g. anemia, infection, blood disorders • Presence of chronic or acute inflammation • Kidney function status and electrolyte disturbances • Potential liver injury, dysfunction or impaired protein production • Mineral imbalances that may affect bones, heart, kidneys, metabolism • Glycemic control or risk of diabetes • Overall cardiovascular risk through lipid profile: balance between “good” and “bad” fats, and total atherogenic burden

A COMPLETE SET OF TESTS THAT CHECK: • kidney and liver function • electrolyte and mineral levels • protein and sugar metabolism • basic blood parameters (red blood cells, white blood cells, platelets) WHAT THIS TEST SUITE REVEALS: • Overall metabolism and organ health • Thyroid hormone balance • Blood sugar control and diabetes risk • Iron stores and anemia risk • A comprehensive picture of lipids and cardiovascular risk

A COMPLETE SET OF TESTS THAT CHECK: • Blood cell counts and types — red cells, white cells, hemoglobin, platelets (FBC) • General inflammation level (ESR) • Electrolytes and kidney filtration — sodium, potassium, chloride, bicarbonate, urea, creatinine, eGFR • Liver enzyme levels and protein synthesis capacity — bilirubin, AST, ALT, GGT, alkaline phosphatase, total protein, albumin, globulin • Mineral and metabolic markers — calcium, phosphate, magnesium, uric acid • Blood glucose — indication of glycemic control or risk of diabetes • Lipid metabolism — triglycerides, total cholesterol • Iron status — including Total Iron Binding Capacity (TIBC) WHAT THIS TEST SUITE REVEALS: • Whether there are abnormalities in blood — anemia, infection, clotting problems • Presence of systemic or chronic inflammation • Kidney health and function, electrolyte balance, possible renal impairment • Liver health: whether there is hepatocellular damage, cholestasis, or protein synthesis issues • Mineral imbalances affecting bones, kidneys, or metabolism • Blood sugar irregularities — prediabetes, diabetes, or metabolic syndrome • Lipid risk factors — general cholesterol levels indicating cardiovascular risk • Iron metabolism — iron deficiency, overload, or binding capacity abnormalities